• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
learn more
view full news & events section

Meeting 5: Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action


The Committee on Addressing Sickle Cell Disease: A Strategic Blueprint and Plan for Action will hold an open session for the public on Wednesday, September 11, 2019. This open session will include a panel of industry speakers who are currently developing therapeutic and curative products for sickle cell disease. The purpose of this session is to have manufacturers share their perspectives with the committee about the range of products in development, the regulatory process, and considerations for ensuring widespread access to pipeline products. More information about this session, including agenda and speakers will be forthcoming.

https://www.onescdvoice.com/wp-content/uploads/2019/08/na_178437.gif

expertly curated content related to this topic

Don’t forget to join the oneSCDvoice community!

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close